NCT06599411View on ClinicalTrials.gov

Identification of Cutaneous and Blood Biomarkers Predictive of Response to Systemic Treatments During Chronic Inflammatory Skin Diseases

Not yet recruitingOBSERVATIONAL
Enrollment

700

Participants

Timeline

Start Date

October 1, 2024

Primary Completion Date

October 1, 2035

Study Completion Date

October 1, 2044

Conditions
Atopic DermatitisPsoriasisHidradenitis SuppurativaLichen PlanusCutaneous LupusDermatomyositisCutaneaous SclerodermaNeutrophilic DermatosisCutaneous GranulomatosisActive Leprosy
Interventions
OTHER

Sampling

Collection of an additional volume of blood Superficial skin biopsy Skin swab

OTHER

Sampling

Collection of an additional volume of blood Preservation of post-operative skin remnants Skin swab

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT06599411 - Identification of Cutaneous and Blood Biomarkers Predictive of Response to Systemic Treatments During Chronic Inflammatory Skin Diseases | Biotech Hunter | Biotech Hunter